##
##
##
##
##
|Charity information|1|
|---|---|
|Report of the Trustees|2
- 7|
|Independent Auditor’s Report|8-10|
|Statement of Financial Activities|11|
|S&ance Sheet|12|
|Statement of Cash Flows|13|
|Notes to the Financial Statements|14—22|
##
##
##
##
##
|2d Floor Aquis House|
|---|
|49-51 Blagrave Street|
|Reading|
|Berkshire|
|Rd
1PL|
|Barclays Bank plc|
|One Churchill Place|
|London|
|E14 5HP|
|Nationwide Building Society|
|Kings Park Road|
|Moulton Park|
|Northampton|
|NN3 6NW|
|fl..:I.j:...... fl....:.,
INeVVL)uI 3t
OLJIIUII 9 OLR..Itly|
|17 Bartholomew Street|
|Newbury|
|RG14 5LY|
|Bevan Brittan|
|35 Colston Avenue|
|Bristol|
|BS1 4TT|
##
#
##
##
##
##
##
##
##
#
##
##
##
##
#
##
##
##
|Sarah Deal||
|---|---|
|Dr Keith Endersby|Secretary|
|Sylvia Galbraith||
|Victoria Hopgood||
|Shane Prater||
|Dr Robert Tayton|Chairman|
|Paul Townsend||
##
|Chairman:||Dr Robert Tayton|
|---|---|---|
|Company|Secretary:|Dr Keith Endersby|
|Bankers:||Barclays Bank plc and Nationwide Building Society|
|Solicitors:||Bevan Brittan|
|Auditors:||UHY Ross Brooke|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||2022|2022|2022|2021|
|---|---|---|---|---|---|---|
|||Notes|Unrestricted|Restricted|Total|Total|
||||Funds|Funds|Funds|Funds|
||||£|£|£|£|
|||||||(Note 18)|
|INCOME AND ENDOWMENTS FROM:|||||||
|Donations and legacies||3|-|138,083|138,083|750,000|
|Incomefrom charitable activities|||||||
|Provision of hospital services|||5,280,885|-|5,280,885|4,960,379|
|Investment income|||14,847|80|14,927|12,682|
|TOTAL|||5,295732|138,163|5,433,895|5,723,061|
|EXPENDITURE ON:|||||||
|Charitable Activities:|||||||
|Cost of hospital services|— contractual||4,770,945|-|4,770,945|4,497,399|
|Cost of hospital services|-voluntary||144,768|138,083|282,851|1,769,363|
|TOTAL||4|4,915,713|138,083|5,053,796|6,267,262|
|NET INCOMEI(EXPENDITURE)|||||||
|BEFORE TRANSFERS|||380,019|80|380,099|(544,201)|
|Transfers between funds||14|||||
|Net ncorne/(expenditure) and net|||||||
|movement in funds in the year|||380,019|80|380,099|(544,201)|
|Tota’ funds at 1 October 2021|||8,825,935|9,171|8,835,106|9,379,307|
|Total funds at 30 September 2022||15|9.205,954|9.251|9.215.205|&835, 106|
##
##
||Notes||2022|2021|
|---|---|---|---|---|
|||£|£|£|
|CURRENT ASSETS|||||
|Debtors:|||||
|Falling due within one year|7|1,372,245||2,028,800|
|Falling due after more than one year|8|8,817,015||9,652,715|
|Cash at bank and in hand||8,643,168||7,515,245|
|||18,832,428||19,196,760|
|CREDITORS: Amounts falhng due within|||||
|one year|9|(1 228,023)||(1,233,736)|
|NET CURRENT ASSETS|||17,604,405|17,963,024|
|CREDITORS: Amounts falling due after more|||||
|than one year|10||(7,096,845)|(7,769,116)|
|Provisions for liabilities and charges|11||(1,292,355)|(1,358,802)|
|TOTAL ASSETS LESS LIABILITIES|||9.215.205|8.835.106|
|Unrestricted funds|13||9,205,954|8,825,935|
|Restricted funds|14||9,251|9,171|
|TOTAL FUNDS|15||9.2iL2f15|8,835,106|
##
##
##
||2022|2021|
|---|---|---|
||£|£|
|Cash flows from operating activities:|||
|Net movement in funds|380,099|(544.201)|
|Amortisation of finance receivable|799,459|764,695|
|Interest received|(14,927)|(12,682)|
|Interest paid|530,398|583.656|
|Decrease/(increase)/in debtors|692,796|(709,660)|
|Increase/(decrease) in creditors|79,982|(46,229)|
|Increase/(decrease) in provisions|(66,447)|(19,398)|
|Net cash provided by operating activities|2,401,360|16.581|
|Cash flowsfrom investing activities|||
|Interest received|14,927|12,682|
|Net cash provided by investing activities|14,927|12,682|
|Cash flows from financing activities|||
|Interest paid|(530,398)|(583,856)|
|Repayment of loan|(757,966)|(855,396)|
|Net cash used in by financing activities|(1,288,364)|(1,439,252)|
|Change in cash and cash equiva!ents in the year|1,127,923|(1,400,980,)|
|Cash and cash equivalents at the beginning of the year|7,515,245|8,925,234|
|Total cash and cash equivalents at the end of the year|8.643.168|7515,245|
||2022|2021|
|Analysis of cash and cash equivalents:|£|£|
|Cash at bank and in hand|8fi44|7,515.245|
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#
##
##
##
##
##
##
##
##
##
##
##
|||2022|2021|
|---|---|---|---|
|Charitable Activities:||£|£|
|Cost of hospital services|- contractual|||
|Facilities management charge||2,393146|Z2Q5,854|
|Management fees||95,220|94,880|
|Sinking fund expenditure||525,787|413,334|
|Model update||6,600|(6,400)|
|Amortisation of finance receivable||794,486|758,600|
|Loan interest||530,398|583,856|
|Insurance||56,170|47,065|
|Variation expenditure recharged||12,836|58.599|
|Amortisation of loan arrangement fees||4,973|6,295|
|Utility charge||327,897|274,160|
|Governance||11,500|15,000|
|Othercosts||11,932|46,156|
|||4,770,945|4,497,399|
|Cost of hospital services|— voluntary|||
|Variation expenditure met by Charity||282,851|19,863|
|Donations for MRI Scanners||-|1,750,000|
|||282,851|1,769,863|
|||5,053.796|6.267,262|
##
##
##
##
||||||2022|2021|
|---|---|---|---|---|---|---|
||||||£|£|
|Auditor’s|remuneration|audit|||11,500|15,000|
|||other|services:-|SPy management|-|94.880|
|||other|services:-|variations|||
##
##
|7.|DEBTORS: Amounts falling due within one year|||
|---|---|---|---|
|||2022|2021|
|||£|£|
||Finance receivable|835,700|799,459|
||Other debtors||750,000|
||Prepayments and accrued income|536,545|479,341|
|||1.372.245|2.028.800|
|8.|DEBTORS: Amounts falling due after more than one year|||
|||2022|2021|
|||£|£|
||Finance receivable|.JJ1Z,015|9,652,715|
|9.|CREDITORS: Amounts falling due within one year|||
|||2022|2021|
|||£|£|
||Building Society
- loan capital repayable within one year|672,271|757,966|
||Trade creditors|328,642|276,404|
||Social Security and other taxes|116,467|83,104|
||Other creditors|9,355|9,275|
||Accruals|101,288|106,987|
|||zL22L023|1,233,736|
##
||2022|2021|
|---|---|---|
||£|£|
|Building Society loan capital due:|||
|lnone—twoyears|748,163|672,271|
|In two
— five years|3,091,163|2,622,109|
|In more than five years|3,257,519|4474,735|
||7.096.845|7769.i16|
##
|Life Cycle and Maintenance|£|
|---|---|
|At 1 October 2021|1,358,802|
|Additions|459,340|
|Amounts used|(525787)|
|At 30 September 2022||
##
##
##
##
|13.|UNRESTRICTED FUNDS|UNRESTRICTED FUNDS|||||
|---|---|---|---|---|---|---|
|||AtI||||At30|
|||October|Incoming|Resources||September|
|||2021|resources|expended|Transfers|2022|
|||£|£|£|£|£|
||Generalfund|8,675935|5,295,732|(4,915713)|(41218)|9,014,736|
||Designated fund|—|||||
||Switchgear|150,000|-|-|-|150,000|
||Covid recovery|*||-|41218|41,218|
|||_.?25.93|_5295.±32|(4.915.713)|||
||The Switchgearfund relates to an electrical upgrade needed for the hospital.||||||
|||Ati||||At30|
|||October|Incoming|Resources||September|
|||2020|resources|expended|Transfers|2021|
|||£|£|£|£|£|
||GeneraF fund|9,270,366|4,972,831|(5,517,262)|(50,000)|8,675,935|
||Designated fund|—|||||
||Switchgear|100,000|-|-|50,000|150,000|
|||fi:370,366|- 4,972.831|J5,517.262)||8.825.935|
|14.|RESTRICTED FUNDS||||||
|||Ati||||At30|
|||October|Incoming|Resources||September|
|||2021|resources|expended|Transfers|2022|
|||£|£|£|£|£|
||Renal Unit|9,171|80||-|9,251|
||Rainbow Rooms|-|35,583|35,583|-|-|
||Switchgear|-|102,500|102,500|||
|||9.171|138.163|138.083|-|9,251|
||Ati||||At30|
|---|---|---|---|---|---|
||October|Incoming|Resources||September|
||2020|resources|expended|Transfers|2021|
||£|£|£|£|£|
|Renal Unit|8,941|230|-|-|9.171|
|MRI Scanners|-|750.000|(750.000)|-|-|
||8,941|750,230|(750.000)|-|9.171|
##
##
##
##
|NALYSIS O|F|NET ASSETS|BETWEEN FUN|DS|||||
|---|---|---|---|---|---|---|---|---|
|2022|||Net current|Long term||||Total|
||||assets|liability|Provisions|Transfers||2022|
||||£|£|£|£||£|
|Unrestricted|—|General fund|17,403,936|(7,096,845)|(1,292,355)||-|9,014,736|
|Unrestricted|—|Designated|191,218|-|-||-|191,218|
|Restricted|||9,251||-|||9,251|
||||17,604.405|(7.096.845)|j.292.35j|||=flP.Z|
|2021|||Net current|Long term||||Total|
||||assets|liability|Provisions|Transfers||2021|
||||£|£|£|£||£|
|Unrestricted—||Generalfund|17,603,853|(7,769,116)|(1,358,802)||-|8,675,935|
|Unrestricted|—|Designated|150,000|-|-||-|150,000|
|Restricted|||9.171|||||9,171|
||||I7.963,Q4|(7.769,116)|(1,358,802,)|||8.835JQ|
##
##
||||2022|2021|
|---|---|---|---|---|
||||£|£|
|Financial assets measured|at fair value|||10,452,174|
|Financial liabilities measured at fair value||||._(1.358,802)|
|ANALYSIS OF CHANGES|IN NET DEBT||||
||01 Oct|Cash-flows|Other non-cash|30 Sep|
||2021||changes|2022|
||£|£|£|£|
|Cash|7,515,245|1,127,923|-|8,643,166|
|Finance receivable due|799,459|(799,459)|835,700|835,700|
|within one year|||||
|Finance receivable after|9,652,715|-|(835.700)|8,817,015|
|more than one year|||||
|Loans falling due within|(757,966)|757,966|(672271)|(672,271)|
|one year|||||
|Loans falling due after|(7,769,116)||672fl|(7,096,845)|
|more than one year|||||
|Total|9,440,337|1,086,430|-|10.526.767|
##
|18.
COMPARATIVE STATEMENT OF|FINANCIAL ACTIVITIES|||
|---|---|---|---|
||2021|2021|2021|
||Unrestricted|Restricted|Total|
||Funds|Funds|Funds|
||£|£|£|
|INCOME AND ENDOWMENTS FROM:||||
|Donations and legacies|-|750,000|750,000|
|Income from charitable activities||||
|Provision ofhospitalservices|4,960,379|-|4,960,379|
|Investment income|12,452|230|12,682|
|TOTAL|4,972,831|750,230|5,723,061|
|EXPENDITURE ON:||||
|Charitable Activities:||||
|Costofhospital services
- contractual|4,497,399|-|4,494399|
|Cost ofhospital services
- voluntary|1,019,863|750,000|1,769,863|
|TOTAL|5,517262|750.000|6,267.262|
|NET INCOME/(EXPENDITURE)||||
|BEFORE TRANSFERS|(544,431)|230|(544,201)|
|Transfers between funds|-|||
|Net income/(expenditure) and net||||
|movement in funds in the year|(544,431)|230|(544,201)|
|Total funds at 1 October 2020|9,370,366|8,941|9,379,307|
|Total funds at 30 September 2021|8.825.935|9.171|8.835,106|